Page last updated: 2024-08-25

lead and Cushing's Syndrome

lead has been researched along with Cushing's Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbosa Junior, F; Bunscheit, V; de Matos, TM; Juster, RP; Lupien, SJ; Marcourakis, T; Plusquellec, P; Souza-Talarico, JN; Suchecki, D	1
Becker, H; Bernhardt, R; Bureik, M; Dragan, CA; Hübel, K; Lenz, N; Scher, J	1

Other Studies

2 other study(ies) available for lead and Cushing's Syndrome

Article	Year
Lead exposure is related to hypercortisolemic profiles and allostatic load in Brazilian older adults. Environmental research, 2017, Volume: 154 Topics: Aged; Aged, 80 and over; Aging; Allostasis; Biomarkers; Brazil; Circadian Rhythm; Cross-Sectional Studies; Cushing Syndrome; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Lead; Male; Middle Aged; Pituitary-Adrenal System	2017
Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension Molecular and cellular endocrinology, 2004, Mar-31, Volume: 217, Issue:1-2 Topics: Cushing Syndrome; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Endomyocardial Fibrosis; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Lead; Recombinant Proteins; Schizosaccharomyces; Steroid 11-beta-Hydroxylase; Substrate Specificity	2004

Article

Year

Lead exposure is related to hypercortisolemic profiles and allostatic load in Brazilian older adults.

Environmental research, 2017, Volume: 154

Topics: Aged; Aged, 80 and over; Aging; Allostasis; Biomarkers; Brazil; Circadian Rhythm; Cross-Sectional Studies; Cushing Syndrome; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Lead; Male; Middle Aged; Pituitary-Adrenal System

2017

Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension

Molecular and cellular endocrinology, 2004, Mar-31, Volume: 217, Issue:1-2

Topics: Cushing Syndrome; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Endomyocardial Fibrosis; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Lead; Recombinant Proteins; Schizosaccharomyces; Steroid 11-beta-Hydroxylase; Substrate Specificity

2004